OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
May 01, 2009
Congress-and the public-needs to take a deep breath before making a big mistake.
Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.
We leap tall buildings to bring you the definitive guide to the world's top pharmaceutical companies.
Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded?
In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing.
European docs have always been down on pharma-but now the US is catching on. Perhaps pharma has oversold the "service model."
Pharma marketers face a crisis in digital media. But there's a way to turn it around.
When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game.
Tough economic tmes call for a bold approach to evolving information technology solutions.
Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.
Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?